학술논문
Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control Laboratory
Document Type
article
Author
Chamberlain, Alanna M; Cooper-DeHoff, Rhonda M; Fontil, Valy; Nilles, Ester Kim; Shaw, Kathryn M; Smith, Myra; Lin, Feng; Vittinghoff, Eric; Maeztu, Carlos; Todd, Jonathan V; Carton, Thomas; O'Brien, Emily C; Faulkner Modrow, Madelaine; Wozniak, Gregory; Rakotz, Michael; Sanchez, Eduardo; Smith, Steven M; Polonsky, Tamar S; Ahmad, Faraz S; Liu, Mei; McClay, James C; VanWormer, Jeffrey J; Taylor, Bradley W; Chrischilles, Elizabeth A; Wu, Shenghui; Viera, Anthony J; Ford, Daniel E; Hwang, Wenke; Knowlton, Kirk U; Pletcher, Mark J
Source
Mayo Clinic Proceedings. 98(5)
Subject
Language
Abstract
ObjectiveTo explore trends in blood pressure (BP) control before and during the COVID-19 pandemic.Patients and methodsHealth systems participating in the National Patient-Centered Clinical Research Network (PCORnet) Blood Pressure Control Laboratory Surveillance System responded to data queries, producing 9 BP control metrics. Averages of the BP control metrics (weighted by numbers of observations in each health system) were calculated and compared between two 1-year measurement periods (January 1, 2019, through December 31, 2019, and January 1, 2020, through December 31, 2020).ResultsAmong 1,770,547 hypertensive persons in 2019, BP control to